NCT02039817: PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers |
|
|
| Completed | 1 | 16 | US | IDN-6556, emricasan, PF-03491390 | Conatus Pharmaceuticals Inc. | Renal Impairment, Renal Insufficiency, Kidney Disease, Kidney Diseases | 04/14 | 04/14 | | |
